The current cost of angina pectoris to the National Health Service in the UK.
about
Pharmacological treatment and perceived health status during 1-year follow up in patients diagnosed with coronary artery disease, but ineligible for revascularization. Results from the Euro Heart Survey on Coronary RevascularizationThe initial management of stable angina in Europe, from the Euro Heart Survey: a description of pharmacological management and revascularization strategies initiated within the first month of presentation to a cardiologist in the Euro Heart Survey oA review of the use of routine data on CHD in general practice research in Scotland.Health Resource Utilization and Direct Costs Associated with Angina for Patients with Coronary Artery Disease in a US Managed Care Setting.A web-based program improves physical activity outcomes in a primary care angina population: randomized controlled trial.The anti-ischemic and anti-anginal properties of statinsCost of an emerging epidemic: an economic analysis of atrial fibrillation in the UKImpact of nicorandil in angina: subgroup analyses.Investigation and management of chest pain.Economic evaluation of the impact of nicorandil in angina (IONA) trial.Hospital volume of throughput and periprocedural and medium-term adverse events after percutaneous coronary intervention: retrospective cohort study of all 17,417 procedures undertaken in Scotland, 1997-2003.How effective are rapid access chest pain clinics? Prognosis of incident angina and non-cardiac chest pain in 8762 consecutive patients.Ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Greece: a cost-utility study.Economic evaluation of trimetazidine in the management of chronic stable angina in GreeceRanolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective.Metabolic therapeutics in angina pectoris: history revisited with perhexiline.Direct medical cost of newly diagnosed stable coronary artery disease in Hong Kong.Cost of illness for chronic stable angina patients enrolled in a self-management education trial.A review of the cost of cardiovascular disease.Recommendations for advancing the care of Canadians living with refractory angina pectoris: a Canadian Cardiovascular Society position statement.Relation between initial treatment strategy in stable coronary artery disease and 1-year costs in Ontario: a population-based cohort studyEffectiveness of Psychoeducational Interventions for Improving Symptoms, Health-Related Quality of Life, and Psychological well Being in Patients with Stable Angina.Impact of self-management interventions on stable angina symptoms and health-related quality of life: a meta-analysis.Cost-effectiveness of enhanced external counterpulsation (EECP) for the treatment of stable angina in the United Kingdom.The feasibility of nurse-led assessment in acute chest pain admissions by means of coronary computed tomography.NICE guidelines for new chest pain: comparison of new and old services.Relative diagnostic, prognostic and economic value of stress echocardiography versus exercise electrocardiography as initial investigation for the detection of coronary artery disease in patients with new onset suspected angina.Costs of heart disease and risk behaviour: implications for expenditure on prevention.Hospital utilization and costs for spinal cord stimulation compared with enhanced external counterpulsation for refractory angina pectoris.Clinical outcomes when applying NICE guidance for the investigation of recent-onset chest pain to a rapid-access chest pain clinic population.Relative clinical and economic impact of exercise echocardiography vs. exercise electrocardiography, as first line investigation in patients without known coronary artery disease and new stable angina: a randomized prospective study.Outcome of stable angina in a working population: the burden of sickness absence
P2860
Q28195632-22778743-3573-4CB4-BEE3-B417EE05DB16Q28217880-DFC6BB80-6914-4CE2-A39E-DB976B297AC5Q31004711-3CBAFE6B-20CC-42F0-9DDA-94135FCCAA73Q33928977-C7981D6A-3820-4B4E-B53B-D721A885E5F7Q34268427-B9963B8C-9EDE-4B9A-AA4A-8A590DD7A7B3Q34477330-7E6AF60C-2FFA-42A1-9C6F-73DF818F64DBQ35582163-0573C20C-CDC4-4B5A-813A-A86D27CE2CE7Q35583243-2CDA0EA4-EB13-4A78-B317-41D24A2AC21CQ35583486-0583AB3E-FF82-490B-B5F5-69D8FDBBDB55Q35771735-FFE13A35-09E9-4B74-B419-82781F675762Q35772712-06307A2D-B1CD-4778-BA52-DD97FD418892Q35773424-EC01CD72-F61E-4DA1-8AFB-69481B861CC4Q35873307-19F4B120-B914-41A0-AD0D-74FEC1DC2520Q36146507-C64456B9-C394-488D-9B3F-BB12828B75C6Q36258672-F9E27A55-EA8E-4F02-970E-7E63DAD77F2BQ36392401-868EF15F-B3B7-49BF-A1C9-5AE2430659FDQ36800798-650DE5EF-CB7F-4B21-88C0-B581268F825EQ37098298-1F80B7D0-5F58-4248-B66F-23F324065BD5Q37293794-71328426-9848-486B-A441-49722F5ECB9FQ37295161-362573AA-013A-4C01-B26F-F6FB661745C1Q37306197-7C8CEBAB-2E4D-4C49-9C50-564C939E0C2BQ37414783-F1F7C271-7485-40B1-AD6C-B21CECA5D358Q37623371-A37A3105-728C-4D1D-8174-C2A3CF1B3AE4Q37731013-FC13507D-744A-4A30-85E1-938B05712B25Q37899380-982CF3B7-34F0-4C33-8447-122B5152F48BQ38113440-49BA43CA-309A-4EEA-94E9-884A31D7E84EQ38635714-1940D829-DDBE-432D-92BA-E8A1B0B28D67Q40028353-FE9EB75F-703F-45CE-BE63-99A94E5275D1Q45001222-87A1BE7B-DFD1-4713-8F51-188863B0D38CQ45162066-0099AA34-018E-4833-910E-D3700122460DQ53165762-A041F6FA-89FD-4FA7-8832-B322C9A6E556Q57315494-2B0ED674-B1D8-4481-9204-677A7CD6AD03
P2860
The current cost of angina pectoris to the National Health Service in the UK.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The current cost of angina pectoris to the National Health Service in the UK.
@ast
The current cost of angina pectoris to the National Health Service in the UK.
@en
type
label
The current cost of angina pectoris to the National Health Service in the UK.
@ast
The current cost of angina pectoris to the National Health Service in the UK.
@en
prefLabel
The current cost of angina pectoris to the National Health Service in the UK.
@ast
The current cost of angina pectoris to the National Health Service in the UK.
@en
P2093
P2860
P356
P1433
P1476
The current cost of angina pectoris to the National Health Service in the UK.
@en
P2093
J J V McMurray
N F Murphy
P2860
P304
P356
10.1136/HEART.89.8.848
P407
P577
2003-08-01T00:00:00Z